Francis Burrows insider trades: Kura Oncology (KURA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Francis reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | KURA | ↓ Sell | 20,726 | $10.83 | $225K | Direct | Sep 25, 2026 (1d) |
| Jan 27, 2026 | KURA | ↓ Sell | 1,311 | $8.46 | $11K | Direct | Jan 27, 2026 (0d) |
| Dec 18, 2025 | KURA | ↓ Sell | 23,726 | $9.78 | $232K | Direct | Dec 19, 2025 (1d) |
| Jan 28, 2025 | KURA | ↓ Sell | 2,166 | $7.87 | $17K | Direct | Jan 28, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KURA insiders
Open-market trades in the last 12 months
About Francis Burrows's insider trades
Francis Burrows is Chief Scientific Officer at Kura Oncology (KURA). Since Jan 28, 2025, Francis has reported no open-market purchases and 4 sales worth $485K on SEC Form 4. In the last 12 months: 3 sales ($468K).
Their filings also include option exercises (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.